Paraganglioma Treatment in Turkey

What is Paraganglioma and What Are Its Typical Symptoms?

A paraganglioma is a rare type of neuroendocrine tumour that develops from specialized nerve cell clusters (chromaffin or non-chromaffin cells) located alongside blood vessels and major nerve pathways outside the adrenal glands. They most commonly occur in the head, neck, chest, abdomen, or pelvis. While many paragangliomas are benign (non-cancerous), some are malignant and can spread to distant tissues like lymph nodes, bones, or the lungs. Medical care for these complex tumours usually falls under specialized departments like Oncology and Neurosurgery.

Symptoms depend heavily on whether the tumour actively secretes catecholamines—hormones such as adrenaline and noradrenaline. Hypersecreting tumours can lead to severe, episodic signs due to adrenaline rushes, whereas non-secretory tumours generally present through structural pressure on surrounding nerves and vessels.

• Persistent or episodic high blood pressure: Often difficult to control with standard medications.
• Classical symptom triad: Sudden severe headaches, unprovoked profuse sweating, and rapid or irregular heartbeats (palpitations).
• Unexplained anxiety or tremor: Sensations similar to a panic attack caused by hormonal spikes.
• Local compression symptoms: Head and neck paragangliomas (such as carotid body tumours) often present as a painless neck mass, pulse-synchronous tinnitus (hearing a thumping sound in the ear), difficulty swallowing, or voice hoarseness.

How Paraganglioma is Diagnosed in Turkey

Accurate diagnosis involves determining the tumour's exact location, assessing whether it secretes excess hormones, and ruling out metastatic disease. When travelling for care, international patients undergo a comprehensive assessment at advanced diagnostic centres. Bringing complete prior records—including imaging scans on DICOM discs and laboratory results—helps the multidisciplinary team plan appropriate testing without unnecessary repetition.

Diagnostic workups typically involve:

• Biochemical testing: Measuring fractionated plasma or 24-hour urinary metanephrines and normetanephrines to check for hormonal activity.
• High-resolution imaging: Contrast-enhanced CT or MRI scans of the head, neck, chest, abdomen, or pelvis to map the precise anatomical relationship between the tumour and adjacent major blood vessels.
• Functional imaging: Specialized nuclear medicine scans, such as Ga-68 DOTATATE PET/CT or MIBG scintigraphy, to identify neuroendocrine receptors, locate small or multiple lesions, and evaluate potential metastases.
• Genetic screening: Up to 40% of paragangliomas are linked to hereditary gene mutations (such as SDHB, SDHD, or VHL). Genetic counseling may be recommended to assess family risk.

Treatment Options for Paraganglioma

Management strategies depend on tumour location, size, hormone secretion, patient fitness, and whether the tumour is localized or metastatic. A team involving oncologists, endocrine surgeons, neurosurgeons, and interventional radiologists determines the safe sequence of care.

Pre-operative medical preparation is vital for hormone-secreting tumours. Doctors strictly administer alpha-adrenergic blockers for 7 to 14 days before surgical interventions to normalize blood pressure and expand intravascular volume, preventing life-threatening hypertensive crises or sudden drop in blood pressure during anesthesia.

Planning Your Medical Travel to Turkey

Navigating paraganglioma treatment abroad requires careful timing and thorough coordination. Because treatment often spans initial stabilization, diagnostic verification, and recovery, patients must plan an adequate length of stay in Turkey.

• Remote medical review: Before travelling, your complete medical history, lab work, and imaging files are evaluated by an oncology team to confirm treatment feasibility and outline estimated schedules.
• Pre-operative preparation time: If your tumour secretes catecholamines, you must spend 1 to 2 weeks locally while medical teams optimize blood pressure blockade before any surgical procedure.
• Duration of stay: Patients undergoing surgery should expect to stay 2 to 3 weeks in total, covering pre-operative preparation, hospital stay, and post-discharge recovery before receiving medical clearance to fly home.
• Follow-up coordination: Before departing, patients receive detailed surgical reports, pathology findings, and long-term surveillance recommendations (such as periodic metanephrine blood tests and yearly imaging) to share with their primary care physician at home.

When Travel is Not Advisable and Urgent Warning Signs

International travel should be deferred if a patient has unmanaged hypertensive crises, severe cardiac arrhythmias, or unstable neurological deficits caused by critical vascular compression in the neck or skull base. Long-haul flying with unblocked hypersecreting tumours carries severe risks due to stress-induced hormone surges.

Seek immediate medical care at the nearest emergency department if you experience any of the following warning signs:

• Extremely high blood pressure readings accompanied by severe, sudden headache or visual disturbances.
• Chest pain, shortness of breath, or severe cardiac palpitations.
• Sudden neurological weakness, facial drooping, or speech difficulty.
• Signs of severe wound infection, fever, or bleeding following recent surgery.